- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 28 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.29: 2 residues within 4Å:- Chain A: N.4, N.124
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: Y.15, N.17, N.48
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: N.112, V.114, V.158
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: H.133, N.136
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain A: N.590
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: H.642, N.644
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: N.696, I.1117, G.1118
- Chain B: D.783
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.48
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain B: N.109, T.111, N.112, V.114, E.141
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.136
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain A: Y.338, I.455
- Chain B: N.151, N.152
Ligand excluded by PLIPNAG.40: 7 residues within 4Å:- Chain A: R.444, N.447, K.449, E.452
- Chain B: T.95, N.221, T.223
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain A: K.545
- Chain B: E.268, N.269
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.590
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.644
Ligand excluded by PLIPNAG.44: 6 residues within 4Å:- Chain B: N.696, I.1117, G.1118
- Chain C: D.783, G.785, P.886
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: Y.15, N.48
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: N.109, T.111, N.112, V.114
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: N.135, N.136, M.140
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain B: Y.338, I.455
- Chain C: N.151, N.152
Ligand excluded by PLIPNAG.49: 7 residues within 4Å:- Chain B: R.444, N.447, K.449, E.452
- Chain C: T.95, N.221, T.223
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: N.267, N.269, T.273
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.590
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: H.642, N.644
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain A: D.783, P.886
- Chain C: N.696, I.1117
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Adams, L.J. et al., A protective antibody targeting the N-terminal domain of SARS-CoV-2 spike recognizes most emerging variants. To Be Published
- Release Date
- 2022-11-23
- Peptides
- Spike glycoprotein: ABC
SARS2-57 Fv heavy chain: D
SARS2-57 Fv light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 28 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Adams, L.J. et al., A protective antibody targeting the N-terminal domain of SARS-CoV-2 spike recognizes most emerging variants. To Be Published
- Release Date
- 2022-11-23
- Peptides
- Spike glycoprotein: ABC
SARS2-57 Fv heavy chain: D
SARS2-57 Fv light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L